Generic and Biosimilar Medicines, Central to Patient Health and Global Healthcare Policies (September 2022)
Experts and leaders from the local and global generic and biosimilar medicines industry, Government and UN agencies, patient organizations, academia and other stakeholders are meeting from 7 to 9 September in Kuala Lumpur, Malaysia to discuss key topics affecting worldwide patient access to affordable medicines, such as...
ViiV Healthcare and the Medicines Patent Pool sign new voluntary licensing agreement to expand access to innovative long-acting HIV prevention medicine (28 July 2022)
MPP invites Expressions of Interest (EoI) from potential sublicensees based anywhere in the world for sublicences to manufacture and sell the cabotegravir long-acting injectable in the licensed territory.
More Articles...
- UICC announces a new global coalition to increase access to and the use of essential cancer medicines in low- and lower middle-income countries (May 2022)
- IGBA’s Newly Launched CEO Advisory Committee Holds Inaugural Meeting with WTO Director General (May 2022)
- IGBA establishes a CEO Advisory Committee (February 2022, Committee updated)
- Generics Industry At The Forefront In War Against COVID-19 In 2021: Generics Bulletin (informa.com) (January 2022)
